ClearCam Inc.的动态

Next week, our CEO, Dr. Will Briggs, and COO, Dr. Cat Kelly, will be attending the inaugural HLTH Europe event in Amsterdam. HLTH is known for its ability to bring together the health ecosystem, connecting leaders from around the world, including providers, payers, government, pharma, startups, and investors. ? Will and Cat will be on the show floor, learning about the latest developments across healthcare, meeting potential partners, and providing insights into the latest innovations from Naitive. ?? Why meet with us? ?? Get insights on how our technology could enhance clinical capabilities in the management of chronic diseases. ?? Learn about how opportunistic screening could redefine the care pathways for musculoskeletal health. Are you attending HLTH? Interested in how our approach could improve population health? Let's meet. ? #HLTH #PopulationHealth #HealthcareInnovation

How will technology planning in?healthcare?facilities evolve in the age of AI and the digital revolution? Hear Nickolas Tournis, PMP's insights and more during the discussion on Impacts of AI on the Design of?Healthcare?Facilities hosted by AMFP NorCal on October 16th.

The emphasis on patient-centricity has increased potential synergies between life sciences companies and patient organizations—a dynamic that the Institute analyzed in last year’s report, Supporting patients through research collaboration: Interactions between patient organizations and life sciences companies. On April 25, 2024, the Institute shared some of these insights in a webinar, Patient Organization Research Collaborations. This insight brief captures key highlights from the presentation — including a high-level framework for forging more effective collaborations. Check it out here: https://bit.ly/4e1Vg6X. #PatientCentricity #GlobalHealth #DataScience #HealthEquity

DREAM BIG - healthier people and healthier communities in a sustainable environment. ? It requires new and different collaboration models with aligned incentives across traditional and non-traditional stakeholders in the healthcare ecosystem, willingness to change and innovate, and a joint commitment towards the big dream...this is exactly what "Clinical Research as a Care Option" is about. ? Thanks so much Janice Chang, Christoph Koenen and Katherine Taylor for inviting me to join this thought-provoking and inspiring panel discussion "The Next Horizon of Clinical Research: Integrating Research into the Care Continuum” at #SCOPEsummit. ? The best way to predict the future is to create it - jointly together. #TransCelerate #ClinicalResearch #ClinicalCare #CRAACO #PatientsFirst

Today, Highlander Health Co-founder Amy Abernethy took the stage at HLTH Inc. in Las Vegas with Joaquin Duato, Johnson & Johnson Chairman & CEO. They discussed their shared passion about utilizing science and technology to solve some of the biggest health care challenges of our time. During the fireside chat they discussed lots of topics, including how curing cancer is considered the ultimate health moonshot. Both agreed that getting treatments approved isn’t enough – we also need them to be widely adopted. They also touched on cardiology and the crucial role technology plays in all phases of health care. The siloed approach of healthcare is not sustainable, and data needs to be easily shared across drug development, med tech and digital health. Amy shared more about Highlander Health’s partnerships to simplify clinical trials and innovate the potential of real-world data. “We want to understand what approaches work across settings, coalesce stakeholders, and embrace the evolution happening in the market right now,” she said. The pair dove into leadership roles as well and the exciting future ahead for health care if we dare to be bold. Thanks for having us #HLTH24

Great initiative! The synergy between patient participation in research and the tremendous scientific & medical progress we experience today underscores the critical role of patient engagement in shaping the future of healthcare.

IP and Contracts- Creating value NOT Chaos- The title of my workshop at the Medilink Midlands Innovation Day on October 3rd delivered in 30 minutes...So expect some fast talking! But seriously, this will be a top tips session covering the most common issues and pitfalls we see and how to avoid/mitigate them. See you there I hope!

It's been a week since our team attended the 2024 SCOPE Summit! It was great to see familiar and friendly faces, participate in thought-provoking conversations on the latest in clinical research execution, and be part of panel discussions with industry leaders. Missed us at the conference? No problem! Check out our webpage to learn about how we're making sure history does not repeat itself: https://lnkd.in/gZQkzW4Q See you next year!? #SCOPESummit #ClinicalResearch

Please go see one of our best talking about the future of sites and clinical trial feasibility at SCOPE on the 13th.

?? #CNSSummit2024 - I’M BACK! Not everyone knows, but SEQSTER’s journey is closely tied to the CNS Summit. Huge thanks to my friend and CNS Summit Chairman & Founder, AMIR KALALI, MD, who believed in SEQSTER early on and helped us secure our first seed funding. In 2017, Amir invited me to share our dream of putting patients at the center—connecting them and researchers with their complete health data. A year later, in 2018, we made health data history by demonstrating SEQSTER's power to unify health records from four different health systems, #DNA data, and remote patient monitoring—all seamlessly integrated into a single longitudinal record with none other than the famous Eric Topol, MD who tweeted it out to his followers. Dr. Topol’s #healthdata from 1985 to the present showcased the future of connected health and that’s when #SEQSTER truly found its place on the map. The CNS community embraced us, except for one voice who challenged our mission, sparking a fire that only strengthened my resolve. That moment proved we had something game-changing. True innovation initially can be viewed with a lot of skepticism, especially when it is solving a monumental problem like data interoperability. Years later, we’re impacting lives at scale and partnering with the top companies in life sciences. It is with this shared history in mind that I’m so proud to be returning to where we came out of stealth and reconnecting with our CNS family—let’s keep pushing boundaries! Looking forward to seeing everyone in #Boston next week. #DigitalHealth #ClinicalTrials #PatientCentric #Interoperability #Innovation #Relentless